Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Down 69.7% in December

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 132,800 shares, a decrease of 69.7% from the November 30th total of 439,000 shares. Based on an average daily volume of 118,279,600 shares, the short-interest ratio is presently 0.0 days.

Therapeutic Solutions International Stock Down 33.3 %

TSOI traded down $0.00 during midday trading on Friday, hitting $0.00. The stock had a trading volume of 172,867,406 shares, compared to its average volume of 21,964,342. Therapeutic Solutions International has a 1 year low of $0.00 and a 1 year high of $0.00.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.